RAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure Rehospitalization
Megadott ok: Recruitment targets will not be met
Key facts
- Where
- Champigny-sur-Marne, Créteil, Eaubonne, Gleizé, Paris, Poitiers, Saint-Denis és Villeneuve-Saint-Georges, FranciaországSee the 8 sites
Where in Franciaország
- Hôpital Paul d'EgineChampigny-sur-Marne, FranciaországNo longer taking part
- Hopital Henri MondorCréteil, FranciaországNo longer taking part
- Hôpital Simone VeilEaubonne, FranciaországNo longer taking part
- Hôpitaux Nord-Ouest de VillefrancheGleizé, FranciaországNo longer taking part
- Hôpital Européen Georges PompidouParis, FranciaországNo longer taking part
- Polyclinique de PoitiersPoitiers, FranciaországNo longer taking part
- Centre Cardiologique du NordSaint-Denis, FranciaországNo longer taking part
- Centre Hopsitalier Lucie et Raymond AubracVilleneuve-Saint-Georges, FranciaországNo longer taking part
Trial details
- Who runs it
- French Cardiology Society
- Trial code
- NCT04703504
- Record updated
- 2024. október 4.
- Original description
The prevalence of heart failure (HF) is constantly increasing in France due to the aging of the population, better management of etiological factors and improved treatments (drug / interventional). On the other hand, re-hospitalizations for heart failure continue to increase, exceeding reception capacities and constitute a real challenge for current public health systems. The PRADO system provides administrative support (through a health insurance advisor) in the management of patient appointments with their doctors as well as home visits by a nurse trained in heart failure. Other interventional medical and educational interventions performed during an out-of-hospital consultation guided by a computer platform would help to optimize the care and continuity of care.Read full original descriptionShow less
The prevalence of heart failure (HF) is constantly increasing in France due to the aging of the population, better management of etiological factors and improved treatments (drug / interventional). On the other hand, re-hospitalizations for heart failure continue to increase, exceeding reception capacities and constitute a real challenge for current public health systems. The PRADO system provides administrative support (through a health insurance advisor) in the management of patient appointments with their doctors as well as home visits by a nurse trained in heart failure. Other interventional medical and educational interventions performed during an out-of-hospital consultation guided by a computer platform would help to optimize the care and continuity of care.
Inclusion: Heart decompensation requiring hospitalization and the use of intravenous diuretic therapy; Left Ventricular Ejection Fraction ≤ 40%.
Exclusion: Hospitalization for cardiac decompensation leading to an invasive procedure (valve, coronary, etc.); Acute reversible cause of heart failure; Incurable disease (other than heart failure) or estimated life expectancy of less than one year; Patient transferred directly to another department or cardiac rehabilitation center; Significant cognitive impairment; Patient without cell phone or email; Linguistic or psychic refusal or inability to sign the informed consent; Current participation in a clinical tria.